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Introduction 
 
In 1966 Dale Webster discovered the first bacterial hemoglobin, 
now known as VHb, in the Gram-negative Vitreoscilla sp. C1 [1].  
Ironically, despite its being a soluble protein, but because of the close 
similarities of its spectral properties to those of the terminal 
respiratory oxidase (cytochrome o), this protein was initially 
identified as “soluble cytochrome o”.  In 1969 Appleby provided 
evidence for a hemoglobin in Rhizobium, but this protein was not 
fully characterized [2].  It was not until the amino acid sequence of 
VHb was determined in 1986, that the real nature of VHb as a 
hemoglobin rather than a soluble cytochrome was apparent [3].  
Although it was fairly clear from VHb’s amino acid sequence that it 
was comprised of a single globin domain without additional structural 
elements, solution of its crystal structure [4] confirmed that the three-
dimensional structure of VHb adheres remarkably closely to the 
classic globin fold. 
In the years since 1986 biochemical, and especially genome 
mining studies, have shown that hemoglobins are widespread among 
microbes.  It was also discovered that bacterial hemoglobins fall into  
  
 
 
 
 
 
 
 
 
  
 
 
three distinct structural categories [5].  One of these is the single 
globin domain (“single domain”) structure exhibited by VHb.  The 
second group (“flavohemoglobins”) is comprised of single subunit 
proteins in which a globin domain highly homologous to that of 
VHb is fused to a flavin-binding (reductase) domain.  The third 
group (“truncated hemoglobins”) contains hemoglobins that are 
considerably smaller than VHb and share a “two over two alpha helix 
structure”; this group can be further classified into three sub-
categories [6].  Truncated hemoglobins are found in bacteria, fungi 
and plants, but not Archaea [6,7]. In addition to bacteria, 
flavohemoglobins can be found in lower eukaryotes [8].  Both the 
flavohemoglobins and truncated hemoglobins are fairly common, but 
the single domain hemoglobins are rarer, so far being found in only a 
handful of bacteria [8].  Two hemoglobins (“protoglobins”) related 
to single domain bacterial globins, but with extra amino acids at both 
termini have been identified in Archaea [9]. 
The functions of the bacterial hemoglobins, although all involving 
oxygen binding in some way, appear to be varied.  The main role of 
the flavohemoglobins appears to be to detoxify NO by converting it 
to NO3─, presumably using both O2 binding by the globin domain 
and reduction via the flavin-binding domain [10,11].  A recently 
characterized flavohemoglobin is able also to oxidize lactate to 
pyruvate [12].  The functions of the truncated hemoglobins have not 
been conclusively determined, but may include scavenging oxygen to 
protect the nitrogen fixing system, and detoxification of NO by its 
conversion to nitrate [6,7]. 
The single (globin) domain VHb has been the best studied of all 
the bacterial hemoglobins, and probably has a number of functions.  
Perhaps its main role is binding of oxygen at low concentrations and 
its direct delivery to the terminal respiratory oxidase(s) (e.g., 
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cytochrome o) [13-15].  This function fits well with VHb’s 
induction at low oxygen [16,17] and the biology of its native host 
(Vitreoscilla), which despite being an obligate aerobe, inhabits 
hypoxic habitats [18].  VHb may have other functions as well, 
including delivery of oxygen to oxygenases [19], detoxification of NO 
by its conversion to nitrate [20], and sensing oxygen concentrations 
and transmitting this information to affect the activity of 
transcription factors [21].  The latter function is presumably related 
to the correlation, found in one study using recombinant E. coli, of 
VHb presence with changes in transcription of hundreds of genes 
[22].  These topics will be discussed in more detail below. 
 
Cloning of the VHb encoding gene, vgb 
  
The gene (vgb) encoding VHb was cloned in 1988 [23,24].  This 
allowed detailed examination of transcriptional control of vgb, use of 
site-directed mutagenesis to explore VHb structure-function 
questions, and, particularly using various strains of recombinant E. 
coli engineered to express VHb, investigation of how VHb functions 
as well as the effects it has on metabolism more generally.  It also 
allowed, beginning in 1990 [25], genetic engineering with vgb of 
what has now become a large group of prokaryotic, lower eukaryotic, 
and higher plant heterologous hosts to improve their usefulness 
(reviewed in [8,26,27]).  Some of these studies will be discussed 
below. 
 
Oxygen binding properties of VHb  
  
Following the correct identification of VHb as a hemoglobin, 
efforts switched to investigate its role as an oxygen binding protein.  It 
was initially proposed that, under oxygen limiting conditions, VHb is 
induced in order to bind the remaining oxygen and deliver it to the 
terminal respiratory oxidase(s) to maintain aerobic respiration at a 
high level under these conditions [28].  Consistent with this role 
evidence was presented that, in E. coli engineered with vgb, much of 
the VHb (about 40 %) is in the periplasm [29].   Ramandeep et al. 
[13], however, provided evidence that the periplasmic location of 
VHb may be an artifact, and that VHb appears instead to be 
concentrated, in both native Vitreoscilla and E. coli expressing VHb, 
in the cytoplasm just below the plasma membrane, where, as would be 
the case for a periplasmic location, it would allow it to interact with 
and deliver O2 to the terminal respiratory oxidases.   
A role for VHb in oxygen delivery to cytochrome o was 
consistent with a report in 1996 [30] indicating that VHb expressed 
in E. coli increased the apparent affinity of cytochrome o for oxygen 
by about 75 %, but had no effect on the oxygen affinity of 
cytochrome d.  Eventually direct evidence was provided to support 
this function.  Ramandeep et al. [13] showed that VHb binds 
specifically to respiratory membranes and to cytochrome o 
incorporated into lipid vesicles, and then Park et al. [14] showed 
through two hybrid screen experiments that there is a direct binding 
of VHb to the catalytic, oxygen binding subunit of the cytochrome 
o’s from Vitreoscilla, E. coli, and Pseudomonas aeruginosa.  A 
subsequent two hybrid screen experiment showed that VHb also 
binds to the catalytic subunit of the alternative, low oxygen induced, 
high oxygen affinity terminal respiratory oxidase, cytochrome d from 
E. coli [15]. 
Equilibrium binding studies measured the dissociation constant of 
VHb for oxygen at about 6 µM [28,31].  Orii and Webster [32] used 
laser flash photolysis to measure both kon and koff for oxygen binding 
to VHb; kon was not remarkable compared to those for other oxygen 
binding proteins, but koff was unusually large [28].  Structurally, this 
may be due to features of the binding pocket of VHb that will be 
discussed below.  Functionally, this may be a feature of VHb that 
optimizes its ability to deliver oxygen to various partner proteins (e.g., 
cytochrome o, oxygenases).  Interestingly, the oxygen dissociation 
constant calculated from the ratio of koff to kon was 12 times greater 
than that measured by the equilibrium binding studies. 
 
Mutants of VHb : Structure-function studies  
 
The oxygen binding properties and abilities of VHb to interact 
with other cellular partners can be correlated with three structural 
features of the protein [4].  One of these is the structural organization 
of its proximal and distal heme sites, which are characterized by lack 
of a proper E helix and E7 gate for the entry and exit of ligands.  A 
second is lack of a defined structure in the D region between the C 
and E helices, which imparts higher structural flexibility to this region.  
Third is a 90° rotation of the imidazole ring of the proximal histidine 
at F8.  This results in a unique hydrogen bonding network involving 
Fe-HisF8-GluH23-TyrG5 that determines the redox potential and 
the electronic structure of the heme iron. A series of VHb mutants, 
with alterations in the distal and proximal heme sites and the D 
region, have been generated that provided valuable structure-function 
information on the role of key residues within these portions of the 
protein (Table 1).  
Structural and ligand binding studies on distal site mutants of 
VHb confirmed that residues E7-E10 in this region do not adopt an 
alpha helical conformation, preventing GlnE7 from performing the 
conventional function of ligand stabilization at the active site [31,33].  
These studies also suggested that the mechanisms of entry, 
stabilization and exit of ligands within the active site of VHb may be 
distinct from those of conventional Hbs. Subsequent studies on other 
VHb mutants demonstrated that the proximal site interactions 
involving TyrG5 contribute significantly to the structural integrity 
and function of VHb [34]. As mentioned above, the D region of 
VHb, connecting helices C and E is disordered and highly flexible. 
Biophysical and ligand binding studies on site directed mutants of 
VHb indicated that the D region is involved in maintaining the heme-
globin stoichiometry and interactions with  partner proteins, in this 
case the flavin domain of 2,4-DNT dioxygenase from Burkholderia 
[35].  The structural flexibility of the D region may allow VHb to 
interact with various partner proteins, in turn allowing it to be 
involved in a variety of cellular functions. 
 
Other functions of VHb 
 
In addition to the apparent direct binding of VHb to terminal 
respiratory oxidases, presumably to deliver oxygen and enhance 
respiration under conditions of low aeration, it appears that VHb has 
a number of other functions, many of which also appear to involve its 
interaction with other proteins. These are summarized in Table 2. 
 
An E. coli mutant strain lacking both terminal oxidases (i.e., both 
cytochromes o and d) and thus unable to grow aerobically was 
engineered to express VHb [36].  The resulting strain was able to 
grow aerobically. In addition, purified VHb added to membranes of 
the engineered double mutant resulted in a 5X increase in respiration, 
and this increase was nearly eliminated by the addition of KCN.  
These results indicate that VHb can itself act as an alternative 
respiratory terminal oxidase.   
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Although VHb exists predominantly as a homodimer, it has also 
been found to exist in a monomeric state under some physiological 
conditions [20].   As mentioned above, it has been speculated that the 
unique structural organization of VHb and the apparent 
conformational flexibility of the D region may allow it to interact 
with different partners and perform multiple cellular functions. An 
NADH-met reductase co-purifies along with VHb in Vitreoscilla 
[37,38] and may be required to keep it in the functional ferrous state 
in the native host to facilitate oxygen delivery to the respiring 
membrane.  As mentioned above, a major role of VHb seems to be to 
deliver oxygen to the terminal respiratory oxidases under conditions 
of limiting aeration.  In particular VHb can interact specifically with 
subunit I of cytochrome o and the A subunit of cytochrome d, which 
in each case is the site of oxygen binding and reduction in respiration 
[14,15]. Although the molecular mechanisms of the VHb interactions 
with cytochromes o and d are not fully understood, these studies 
indicate its involvement in supporting cellular respiration in a unique 
way.  
Construction of a chimeric gene in which a flavoreductase domain 
encoding region is fused with vgb results in a flavoHb like hybrid 
protein that interacts with nitric oxide and relieves the toxicity of 
nitrosative stress in E. coli [20].  The same study also indicated that 
VHb itself may interact with an independent flavoreductase protein 
for this function.  In addition, there is evidence that VHb may be able 
to deliver oxygen directly to oxygenases involved in aerobic catabolism 
of aromatic compounds [19]; this is discussed in more detail below. 
VHb also displays a high propensity for lipid binding that results in a 
several fold decrease in its oxygen affinity and increase in its oxygen 
release [39].  This opens the possibility that interactions of VHb with 
other non-protein cellular components may modulate its function in 
diverse ways.   
 
A recent study demonstrated that the redox state of the cell 
mediates interactions of VHb with the global transcription regulators, 
OxyR and Fnr, which in turn may affect metabolism in a broad way 
[21].  These and perhaps similar, yet undiscovered regulatory 
functions for VHb may be reflected in the results of a microarray 
study on E. coli expressing VHb. These results indicated that the 
presence of VHb brings about significant changes in expression of 
hundreds of genes, including those in almost every category of cellular 
function [22].   Isarankura-Na-Ayudhya et. al. [40] also found that 
VHb expression in E. coli could affect the levels of proteins in several 
different metabolic categories.   Another study found a five fold 
increase in the level of cytochrome o and 1.5 fold increase in the level 
of cytochrome d in VHb expressing E. coli under microaerobic 
conditions [30].  Effects of VHb expression on specific aspects of 
metabolism have been the focus of a number of other studies; these 
are detailed in the following section.  
 
Metabolic changes correlated with VHb expression 
 
Table 3 summarizes the effects on various parts of metabolism 
that have been correlated with VHb expression. Even before the 
correct identification of VHb as a hemoglobin, some aspects of its 
activities and effects on metabolism were investigated in its native 
host, Vitreoscilla.   One of these is related to the induction of VHb 
synthesis by low aeration conditions [16]. Eventually, this induction 
was found to occur at the transcriptional level [17].   In E. coli vgb 
Vitreoscilla hemoglobin 
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appears to be transcriptionally controlled by at least three oxygen 
responsive transcription factors (ArcA, Fnr, and OxyR) as well as Crp 
[21,41-43]. By a mechanism which is as yet undetermined, the 
induction in VHb levels is coordinated with a large (50-fold) increase 
in heme biosynthesis, to supply each VHb dimer with its two 
necessary heme b groups [16]. 
It was also found early on that VHb has hydrogen peroxide 
synthesizing activity [44] and may be able, in its oxidized (Fe+3) form, 
to detoxify superoxide by the reaction: VHb(Fe+3) + O2¯  
VHb(Fe+2) + O2 [45].   
 
 
 
 
 
The proposed (and eventually substantiated; see above) role for 
VHb in enhancing aerobic respiration was also investigated from the 
standpoint of VHb-correlated changes in cellular ATP and NADH 
levels, the hypothesis being that ATP levels might increase and 
NADH levels decrease due to enhanced respiration.  Chen and Bailey 
[46] found no increase in ATP levels or transmembrane ∆pH in 
VHb-expressing E. coli compared to VHb-negative controls but the 
faster growth rate of the VHb strain and an additional NMR study 
suggested increases in ATP synthesis of 68 % and ATP flux of 30% 
due to VHb expression.  An additional study comparing the same two 
strains, however, indicated an increase in ATP level of about two-fold, 
as well as increases of 50-60 % in H+/O and transmembrane ∆pH 
that were correlated with VHb expression [47].   
Tsai et al. [48] used measurements of a number of metabolites 
(but not direct measurement of either ATP or NADH) to model 
ATP and NADH flux, again in E. coli expressing VHb compared to 
the VHb-free control strain. The model suggested a modest increase 
(17 %) in ATP flux and a somewhat larger increase (56 %) in 
NADH flux correlated with VHb expression.  NAD(P)H levels and 
rate of net generation of NAD(P)H were again investigated in VHb-
expressing E. coli and in this case, compared to the VHb-free control 
strain, these parameters decreased by 1.8-fold and 2.4-fold, 
respectively [49].   A subsequent study, again using VHb-expressing 
E. coli, found an approximately 60 % increase in ATP levels 
associated with VHb presence [50]. 
In the experiments described above essentially only a single stage 
in the cultures, for the most part either late log/early stationary phase 
or what can be inferred to have been stationary phase, was sampled.  A 
more recent study of ATP and NADH/NAD+ levels, again in E. 
coli engineered to express VHb and compared against the matched 
control strain without VHb, was made from log through stationary 
phases [51].  Levels of ATP, NAD+, and NADH decreased by large 
amounts in both VHb+ and VHb¯ cells from log through stationary 
phases.  There was a tendency for (roughly two-fold) higher ATP 
levels in the VHb¯ cells in log phase but nearly identical ATP levels 
for both strains in stationary phase.  The NADH levels of the two 
strains were similar in log phase, but that of the VHb¯ cells was 
about twice that of the VHb+ cells in stationary phase. 
Taken together the measurements that have been made on ATP 
and NADH levels in recombinant E. coli expressing VHb compared 
with those in VHb¯ cells are not completely consistent, but do 
indicate that the presence of VHb does not have large effects on 
NADH and ATP levels.  The most consistent result is that VHb is 
correlated with an about 50 % decrease in NADH levels.  This 
corresponds to the apparent role of VHb in enhancing aerobic 
respiration, in which case greater amounts of NADH would be fed 
into the electron transport chain.   In the case of ATP levels, it may 
be that ATP synthesis is increased somewhat due to VHb and its 
attendant enhancement of aerobic oxidative phosphorylation, and that 
the added ATP is used to result in faster growth and increased 
production of certain metabolites, leading to a steady state ATP level 
similar to VHb¯ cells [46,51]. 
 
The effects of VHb expression on metabolism more generally has 
been investigated to some degree, usually using recombinant E. coli.  
An early study [52] showed that expression of VHb in E. coli did not 
alter the rate of acid synthesis. Two later studies [48,50] measured 
production of acetate, ethanol, formate, D-lactate, succinate, and CO2 
by matched strains of E. coli, one expressing and one not expressing 
VHb, under conditions of low oxygen.  Although carbon balance was 
met for both strains in both studies, the results were very different.  In 
[48], VHb was correlated with a lowered production of all products 
(by 25-72 %) and lowered excreted pyruvate (by up to 3-fold).  In 
[50]  VHb was correlated with an ~ 60 % increase in CO2 
production, with sizable increases in ethanol and lactate production, a 
slight increase in succinate production, and sizable decreases in 
production of only acetate and formate. 
In [48] the measured data were incorporated into a model of a 
portion of E. coli metabolism (glycolysis, the TCA cycle, the pentose 
phosphate shunt, and mixed acid fermentation).  The model suggested 
that the presence of VHb resulted in a shift of carbon input away 
from the TCA cycle to the pentose phosphate pathway.  The study by 
Frey et al. [50] also used the measured data in a carbon flux model 
and concluded that VHb results in increased flux through glycolysis 
and branching of the TCA cycle.  Because the actual measurements of 
metabolites in the two studies were so different, however, a firm 
picture of how VHb presence changes these portions of metabolism is 
not yet available. 
Simpler analyses, looking at the effects of VHb expression on 
levels of one or a few metabolites have been performed on several 
engineered microbes.  Saccharomyces cerevisiae engineered with VHb 
showed an apparent increase of about 30 % in ethanol production, 
but the results were complicated by the fact that the ethanol 
measurements were made in stationary phase for the VHb-expressing 
strain and late log phase for the VHb¯ strain [53].  Wei et al. [54] 
engineered Serratia marcescens to express VHb and measured its 
effects on fermentation (total acid, acetoin, and butanediol 
production).  The effects were growth medium dependent, but the 
most consistent occurred in LB supplemented with glucose, in which 
VHb was correlated with lower acetoin and butanediol production as 
well as much higher acid accumulation in stationary phase.  A similar 
study in Enterobacter aerogenes [55] showed that VHb expression 
was correlated with increases of ~ 50-80 % in acetoin and butanediol 
production. 
Vitreoscilla hemoglobin 
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In the process of investigating the positive effects of VHb 
expression in heterologous bacterial hosts to improve a variety of 
useful properties, several bioremediating bacteria (Pseudomonas, 
Xanthomonas, and Burkholderia species) were engineered to express 
VHb [56-64; reviewed in 65,66].  Increases of 15-73 % in (aerobic) 
biodegradation of benzoic acid, dinitrotoluene and 2-chlorobenzoic 
acid were correlated with VHb expression.  It is presumed that VHb-
mediated delivery of oxygen to the respiratory chain, as described 
above, may be responsible for at least some of this enhancement.  
Direct delivery of oxygen to the oxygenases involved in aromatic 
metabolism may also be involved. The first enzyme in the 2,4-
dinitrotoluene degradation pathway of Burkholderia strain DNT 
(DNT dioxygenase) was expressed in E. coli both with and without 
VHb, VHb being correlated with a 3-4 fold increase in the activity of 
the enzyme in whole cell extracts [67].  Addition of purified VHb to 
partially purified DNT dioxygenase in vitro resulted in a 2.7 fold 
increase in dioxygenase activity compared to reactions without added 
VHb [19].  The latter experiment is most easily interpreted if VHb 
interacts directly with the dioxygenase (as a partner protein; see also 
above) to deliver molecular oxygen to it.   
Experiments in which expression of VHb in Burkholderia strain 
DNT enhanced degradation of dinitrotoluene and 2-chlorobenzoate 
(2-CBA) provided details of the effects of VHb on physiology and 
biochemistry.  So et al. [63] found that Burkholderia strain DNT 
expressing VHb (strain YV1) had an oxygen uptake rate and affinity 
for carbon substrate that were about twice those of the matched strain 
not expressing VHb (strain DNT).  A similar (about two-fold) 
increase in affinity for 2-CBA was seen for strain YV1 compared to 
strain DNT [61].   
Perhaps more interesting are indications from experiments on the 
same pair of strains metabolizing 2-CBA; in these experiments VHb 
was correlated with the choice of catabolic pathway by which 2-CBA 
was metabolized [60].  Under low aeration conditions, where the 
effects of VHb are expected to be most apparent, strain DNT 
appeared to metabolize 2-CBA by a mixture of pathways that resulted 
in a minority of the 2-CBA being mineralized and apparent 
accumulation of chlorine containing intermediates that then inhibited 
further 2-CBA metabolism.  Under the same conditions strain YV1 
utilized pathway(s) that resulted in mineralization of essentially all of 
the 2-CBA and avoided production of the inhibitory compounds.  It 
is possible that this effect is related to either a general increase in 
oxygen supply to the cells mediated by VHb, or a preference of VHb 
for oxygen delivery to particular oxygenases. 
  
Two recent studies using an ethanologenic strain of E. coli (strain 
FBR5 [68]) examined the effects of VHb on ethanol production in a 
variety of growth media (LB supplemented with glucose, xylose, or 
corn fiber hydrolysate) and growth conditions [51,69].  Strain FBR5 
was engineered at the Fermentation Biochemistry Research Unit of 
the National Center for Agricultural Utilization Research, Peoria, IL; 
this strain has been mutated so that all naturally occurring 
fermentation pathways have been blocked, and then transformed with 
the ethanol pathway from Zymomonas mobilis encoded on plasmid 
pLOI297 [70] so that it produces only ethanol by fermentation. 
FBR5 was transformed with plasmid pTS3, which is compatible with 
pLOI297 and contains vgb in a construct that results in a moderate 
level of VHb expression [69].  This VHb level was correlated with 
increases in ethanol production that were found consistently across a 
variety of growth media and conditions, although the amount of the 
increase was variable (a range of approximately 10-300 %) and 
medium (LB supplemented with either xylose, glucose, or corn fiber 
hydrolysate) and condition (shake flasks versus fermenters; aerobic 
versus limited aeration) dependent.   
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The increase in ethanol correlated with VHb expression appears 
to be the biological correlate of results from several groups that have 
investigated the effects on the production of 2,3-butanediol and 
ethanol resulting from supplying cultures (mechanically) with small 
amounts of oxygen.  Jansen et al. [71] found optimal 2,3-butanediol 
productivity by Klebsiella oxytoca at an oxygen supply greater than 
zero, while Okuda et al. [72] and Nieves et al. [73] found ethanol 
production by ethanologenic E. coli to be increased by about 25 %  
by addition of small amounts of air to the cultures.  Thus, the effect 
of VHb on enhancing ethanol levels is presumed to be related to the 
increase in oxygen supply it provides to cells, although the details of 
what that mechanism might be are as yet unknown. 
 
Summary and outlook 
 
It is clear that genetic engineering using vgb/VHb can be used to 
enhance biological production of a variety of potentially valuable 
compounds by microbes and even the growth and robustness of 
higher plants. It is also clear that the optimization of such 
applications will require a comprehensive understanding of how 
expression of VHb affects physiology and metabolism. Although 
much work has been done to try to determine these effects, because of 
the fragmentary nature of the investigations and variability of results 
in some cases, such a comprehensive understanding has not yet been 
achieved.  
What is known is that the presence of VHb seems to affect steady 
state concentrations and rates of production of ATP and NADH 
modestly, and also may affect production of fermentation products, 
oxygen uptake in some cases, and affinity of cells for various 
substrates.  In the case of 2-CBA metabolism by Burkholderia strain 
DNT, VHb seems to be involved in the choice of catabolic pathways.  
The details of how VHb affects physiology and metabolism likely 
involve, at least in some cases, its direct interaction with partner 
proteins, examples of which were discussed above.  These interactions, 
in turn, must be related to VHb structure, both in its oxygen binding 
site where oxygen binding and delivery properties are determined, as 
well as elements such as the D region, which may provide a flexible 
binding site for multiple partners. 
Future studies that are able to coordinate VHb structure-function 
data, information on interaction of VHb with partner proteins, and 
more robust information regarding how VHb affects metabolic 
pathways will undoubtedly lead to design of improved systems in 
which VHb expression is used to enhance valuable biological 
processes. 
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